Results 21 to 30 of about 55,360 (258)

Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study

open access: yesRadiation Oncology, 2018
Background The usefulness of particle therapy for skull base chordoma has not been established. The aim of this retrospective study was to analyse the treatment outcomes of proton therapy (PT) and carbon ion therapy (CIT) in patients with skull base ...
Masaru Takagi   +14 more
doaj   +1 more source

Proton beam therapy is a safe and effective treatment in elderly patients with esophageal squamous cell carcinoma

open access: yesThoracic Cancer, 2020
Background There are many elderly patients with esophageal squamous cell carcinoma (ESCC). However, there are currently few articles regarding the clinical outcome following proton beam therapy in these patients. The purpose of this study was to evaluate
Takashi Ono   +4 more
doaj   +1 more source

Proton beam therapy in the management of skull base chordomas: systematic review of indications, outcomes, and implications for neurosurgeons [PDF]

open access: yes, 2016
BACKGROUND: Chordomas are rare tumours affecting the skull base. There is currently no clear consensus on the post-surgical radiation treatments that should be used after maximal tumour resection.
Choi, D, Matloob, SA, Nasir, HA
core   +1 more source

Proton beam therapy for the isolated recurrence of endometrial cancer in para-aortic lymph nodes: a case report

open access: yesBMC Women's Health, 2022
Background Proton beam therapy penetrates tumor tissues with a highly concentrated dose. It is useful when normal structures are too proximate to the treatment target and, thus, may be damaged by surgery or conventional photon beam therapy.
Kaname Uno   +5 more
doaj   +1 more source

Scintillating fiber devices for particle therapy applications [PDF]

open access: yes, 2018
Particle Therapy (PT) is a radiation therapy technique in which solid tumors are treated with charged ions and exploits the achievable highly localized dose delivery, allowing to spare healthy tissues and organs at risk.
Battistoni, G.   +19 more
core   +1 more source

Hybrid Compton-PET imaging for Ion-Range Monitoring in Hadron Therapy [PDF]

open access: yesEPJ Web of Conferences
Hadron therapy is a rapidly growing cancer treatment, offering high precision in targeting tumors while sparing healthy tissue. However, its full potential is limited by uncertainties in the range of therapeutic ions, largely due to current reliance on X-
Balibrea-Correa J.   +12 more
doaj   +1 more source

The clinical case for proton beam therapy

open access: yesRadiation Oncology, 2012
Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing.
Foote Robert L   +21 more
doaj   +1 more source

Successful treatment with proton beam therapy for a solitary sternal metastasis of breast cancer: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Breast cancer infrequently metastasizes to the sternum as solitary metastasis. We experienced successful treatment with proton beam therapy for a case of sternal metastasis of breast cancer.
Yojiro Ishikawa   +8 more
doaj   +1 more source

Towards Laser Driven Hadron Cancer Radiotherapy: A Review of Progress [PDF]

open access: yes, 2014
It has been known for about sixty years that proton and heavy ion therapy is a very powerful radiation procedure for treating tumours. It has an innate ability to irradiate tumours with greater doses and spatial selectivity compared with electron and ...
Bolton, P. R.   +3 more
core   +3 more sources

Performance prediction of gamma electron vertex imaging (GEVI) system for interfractional range shift detection in spot scanning proton therapy

open access: yesNuclear Engineering and Technology, 2022
The maximum dose delivery at the end of the beam range provides the main advantage of using proton therapy. The range of the proton beam, however, is subject to uncertainties, which limit the clinical benefits of proton therapy and, therefore, accurate ...
Sung Hun Kim   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy